[PDF][PDF] Immediate and midterm outcomes following primary PCI with bioresorbable vascular scaffold implantation in patients with ST-segment myocardial infarction …
A Ielasi, B Cortese, A Varricchio, M Tespili… - …, 2015 - academia.edu
Aims: In this multicentre prospective registry we sought to evaluate the immediate and
midterm clinical outcomes following single or multiple overlapping bioresorbable vascular …
midterm clinical outcomes following single or multiple overlapping bioresorbable vascular …
Clinical findings after bioresorbable vascular scaffold implantation in an unrestricted cohort of patients with ST-segment elevation myocardial infarction (from the RAI …
E Moscarella, A Ielasi, A Varricchio… - International journal of …, 2018 - Elsevier
Background The bioresorbable vascular scaffold (BVS) technology may be an appealing
option in ST-segment elevation myocardial infarction (STEMI) patients. However, the …
option in ST-segment elevation myocardial infarction (STEMI) patients. However, the …
One-Year Clinical and Computed Tomography Angiographic Outcomes After Bioresorbable Vascular Scaffold Implantation During Primary Percutaneous Coronary …
P Widimsky, R Petr, P Tousek, M Maly… - Circulation …, 2015 - Am Heart Assoc
Background—Bioresorbable vascular scaffolds (BVS) represent promising new technology,
but data on their long-term outcomes in ST-segment–elevation myocardial infarction …
but data on their long-term outcomes in ST-segment–elevation myocardial infarction …
Three-year results of ST-segment elevation myocardial infarction patients treated with a prespecified bioresorbable vascular scaffold implantation strategy: bVS STEMI …
E Moscarella, G Campo, M Leoncini… - Journal of …, 2022 - journals.lww.com
Methods Design and mid-term results of BVS STEMI STRATEGY-IT (NCT02601781) were
described elsewhere. 9, 10 The decision to prolong DAPT beyond 1 year was initially left to …
described elsewhere. 9, 10 The decision to prolong DAPT beyond 1 year was initially left to …
[PDF][PDF] Long-term follow-up after bioresorbable vascular scaffold implantation in STEMI patients: PRAGUE-19 study update
P Toušek, V Kočka, M Malý, M Kozel, R Petr… - …, 2016 - researchgate.net
Aims: Early clinical results after implantation of bioresorbable vascular scaffolds (BVS) in ST-
elevation myocardial infarction (STEMI) are encouraging, but long-term data are missing …
elevation myocardial infarction (STEMI) are encouraging, but long-term data are missing …
TCT-408 Thirty-day outcome following polymeric bioresorbable scaffold implantation in 347 STEMI patients enrolled in the multicenter “Registro Absorb Italiano”(RAI …
A Ielasi, E Moscarella, B Loi, B Cortese… - Journal of the American …, 2016 - jacc.org
Background Bioresorbable vascular scaffold (BRS) technology appears to be an appealing
option in ST-elevation myocardial infarction (STEMI) patients. The available evidence on …
option in ST-elevation myocardial infarction (STEMI) patients. The available evidence on …
TCTAP A-013 Nine-Month Outcomes Following Primary PCI with Bioresorbable Vascular Scaffold Implantation in Patients with ST-Segment Myocardial Infarction …
A Ielasi, BC Cortese, A Varricchio, M Tespili… - Journal of the American …, 2015 - jacc.org
Background Newer-generation DES may be considered the standard of care for the
treatment of STEMI patients undergoing primary PCI. However, the implantation of these …
treatment of STEMI patients undergoing primary PCI. However, the implantation of these …
Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study 'Prague 19'
V Kočka, M Malý, P Toušek, T Buděšínský… - European heart …, 2014 - academic.oup.com
Abstract Aims Bioresorbable vascular scaffolds (BVSs) have been studied in chronic
coronary artery disease, but not in acute ST-segment elevation myocardial infarction …
coronary artery disease, but not in acute ST-segment elevation myocardial infarction …
A 12–month angiographic and optical coherence tomography follow‐up after bioresorbable vascular scaffold implantation in patients with ST‐segment elevation …
J Kochman, M Tomaniak, Ł Kołtowski… - Catheterization and …, 2015 - Wiley Online Library
Objectives The aim of the study was to evaluate the healing process at 12 months after
ABSORB™ bioresorbable vascular scaffold (BVS) implantation in patients with ST‐segment …
ABSORB™ bioresorbable vascular scaffold (BVS) implantation in patients with ST‐segment …
Long-term outcomes of bioresorbable vascular scaffold in ST-elevation myocardial infarction
Q de Hemptinne, F Picard, HQ Ly, R Ibrahim… - Acta …, 2018 - Taylor & Francis
Background: Bioresorbable vascular scaffolds (BVS) implantation in selected patients with
stable angina has been demonstrated feasible and safe. However, limited data are currently …
stable angina has been demonstrated feasible and safe. However, limited data are currently …